Introduction
Introduction

Osteopontin (OPN), also known as Eta-1 (early T lymphocyte activation-1), is a key cytokine promoting the release of interleukin (IL)-12 and hence inducing the development of a Th1 immune response
. OPN has been cloned for the first time in 1986 and has long been considered a structural bone protein linking bone cells to the bone extracellular matrix. It belongs to a protein family called SIBLINGs (small integrin-binding ligand N-linked glycoprotein), whose genes share common expression in bone and tooth, and encode among others an RGD motif (amino acid sequence arg-gly-asp) [3] . It is both a membrane bound as well as a secreted protein, which binds to multiple receptors, depending on its phosphorylation state, such as the integrin receptor ␣V␤3, the CD44 variant isoforms CD44v6 and CD44v7 and components of the extracellular matrix such as collagen type I [4] [5] [6] . Intracellular [7, 8] .
OPN binding to CD44 variant isoforms establishes the survival signal by complex formation with the ERM (ezrin/radixin/moesin)
Osteopontin as two-sided mediator of intestinal inflammation
In its soluble form OPN is a strong chemoattractant and a proinflammatory cytokine that functionally activates dendritic cells and macrophages and induces their differentiation towards a
Th1-polarizing phenotype [1] . [10] . Recently 
OPN, produced by epithelial cells and mononuclear cells, enables IL-12 release through integrin engagement and dampens the IL-10 response through CD44 binding in macrophages [1]. It has been suggested that this binding of the same molecule to two different receptors on a cell differentially regulates the key cytokines towards type 1 immunity [1]. In inflammatory bowel disease (IBD), a dysregulated immune response to bacterial or food antigens plays a major role. Crohn's disease (CD) is characterized as a Th1 directed immune response with increased CD4 ϩ T-cell production of interferon (IFN)-␥ and activated macrophages that secret tumour necrosis factor (TNF)-␣ and IL-12 [9]. In contrast, ulcerative colitis (UC) is associated with an atypical Th2 response mediated by a distinct subset of NK T cells that produce IL-13 and are cytotoxic for epithelial cells
Real-time RT-PCR
RNA analysis
Total RNA of LPMC from OPN -/-and WT mice with acute and chronic inflammation versus healthy mice was isolated using the RNeasy kit from Qiagen (Hilden, Germany). Five hundred nanograms of total RNA were reverse transcribed as described elsewhere [23] . TLR2, 4 and 9 were detected using the primers as described [24] . NOD2 was amplified using the primers as described [25] . (Fig. 3E) .
Statistical analysis
OPN deficiency causes different systemic cytokines responses
In Fig. 4A) . (Fig. 4D) . [54, 55] .
Correspondingly, the OPN -/-mice showed reduced serum levels of IL-22 (Fig. 4B) at day 4 and IL-17A (Fig. 4C). Interestingly, the levels of TNF-␣ in these samples were elevated in OPN -/-in comparison to WT mice during acute DSS colitis (Fig. 4B). The application of recombinant OPN increased IL-17 blood levels in OPN -/-mice comparable to those of WT mice (Fig. 4C) (in these samples the levels of IL-22 and TNF-␣ were not evaluated). Lastly, the secretion of IFN-␥ and IL-10 was evaluated from MLN cells in WT and OPN -/-mice in acute (day 7) and in chronic colitis (day 26). In line with the mRNA results, no differences in the IFN-␥ levels were observed in acute colitis in OPN -/-compared to WT mice. However, in the chronic DSS colitis, IFN-␥ levels were significantly lower in OPN -/-mice (P Ͻ 0.01), whereas IL-10 secretion was increased (P Ͻ 0.001) compared to WT mice (Table 2). During the second, chronic, DSS treatment period at day 24, but not during the first DSS treatment period at day 0, we found a clear reduction of IL-12 mRNA expression in MLNs
Serum OPN correlates with disease activity status in CD patients
